Discure Technologies

The Discure System is designed to treat and reverse degenerative disc disease (DDD), healing the discs, reducing pain, and restoring function to patients, via a minimally invasive, implantable bioelectronic approach. Unlike existing treatments, that are symptom-focused, the Discure System is a disease-modifying solution, designed to reduce the use of opioids and the need for invasive back surgery. The company received FDA Breakthrough Device Designation, and an award for “Best New Technology in Spine Care in 2021” at the North American Spine Society (NASS) annual meeting, by a panel of KOL spinal surgeons and neurosurgeons. Investors include Rainbow Medical, Johnson & Johnson and multiple venture arms of US-based hospital networks.